false 0001888734 0001888734 2024-12-10 2024-12-10 0001888734 us-gaap:CommonStockMember 2024-12-10 2024-12-10 0001888734 GLLI:WarrantsMember 2024-12-10 2024-12-10 0001888734 us-gaap:RightsMember 2024-12-10 2024-12-10 0001888734 GLLI:UnitsMember 2024-12-10 2024-12-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

Current Report

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

December 10, 2024

Date of Report (Date of earliest event reported)

 

GLOBALINK INVESTMENT INC.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware   001-41122   36-4984573

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

200 Continental Drive, Suite 401

Newark, Delaware

  19713
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: +6012 405 0015

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   GLLI   The Nasdaq Stock Market LLC
Warrants   GLLIW   The Nasdaq Stock Market LLC
Rights   GLLIR   The Nasdaq Stock Market LLC
Units   GLLIU   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 
 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

Extension of the Termination Date

 

On December 10, 2024, Globalink Investment Inc., a Delaware corporation (the “Company”), received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) that the Company was not in compliance with Nasdaq Listing Rule IM-5101-2, which requires a special purpose acquisition company to complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. Since the Company failed to complete its initial business combination by December 6, 2024, the Company did not comply with IM-5101-2, which triggered the issuance of a delisting determination from Nasdaq to delist the Company’s securities.

 

According to the Notice, the Company’s common stock, warrants, rights and units will be suspended at the opening of business on December 17, 2024, and a Form 25-NSE will be filed with the U.S. Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from listing and registration on Nasdaq. The Company does not intend to appeal this ruling.

 

The Company plans to transfer its securities, including common stock, warrants, rights and units, to OTC Pink for quotation under the same ticker symbols following the delisting of the Company’s securities on Nasdaq.

 

As previously disclosed in a current report on Form 8-K of the Company, dated May 24, 2024, on May 20, 2024, the Company, Alps Global Holding Pubco, a Cayman Islands exempted company (“PubCo”), Alps Biosciences Merger Sub, a Cayman Islands exempted company and wholly-owned subsidiary of PubCo (“Merger Sub”), Alps Life Sciences Inc, a Cayman Islands company (“Alps Holdco”), GL Sponsor LLC, a Delaware limited liability company, in the capacity as the representative for the stockholders of the Company (the “Parent Representative”), and Dr. Tham Seng Kong, an individual, in the capacity as the representative for the shareholders of Alps (the “Seller Representative”) entered into an amended and restated merger agreement (the “Merger Agreement”), which contemplates a business combination between the Company and Alps Holdco (the “Business Combination”). Following the delisting of its securities, the Company expects to continue proceeding with the transactions contemplated by the Merger Agreement.

 

Cautionary Statement Regarding Forward-Looking Statements

 

Certain statements in this Current Report on Form 8-K are “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this Current Report on Form 8-K, words such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential” or “continue”, or variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. All statements other than statements of historical fact contained in this Current Report on Form 8-K are forward-looking statements. The Company does not undertake any obligation to update forward-looking statements as a result of new information, future events or developments or otherwise.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: December 12, 2024

 

  GLOBALINK INVESTMENT INC.
     
  By: /s/ Say Leong Lim
  Name: Say Leong Lim
  Title: Chief Executive Officer

 

 

 

v3.24.3
Cover
Dec. 10, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 10, 2024
Entity File Number 001-41122
Entity Registrant Name GLOBALINK INVESTMENT INC.
Entity Central Index Key 0001888734
Entity Tax Identification Number 36-4984573
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 200 Continental Drive
Entity Address, Address Line Two Suite 401
Entity Address, City or Town Newark
Entity Address, State or Province DE
Entity Address, Postal Zip Code 19713
City Area Code +6012
Local Phone Number 405 0015
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Common Stock [Member]  
Title of 12(b) Security Common Stock
Trading Symbol GLLI
Security Exchange Name NASDAQ
Warrants  
Title of 12(b) Security Warrants
Trading Symbol GLLIW
Security Exchange Name NASDAQ
Rights [Member]  
Title of 12(b) Security Rights
Trading Symbol GLLIR
Security Exchange Name NASDAQ
Units  
Title of 12(b) Security Units
Trading Symbol GLLIU
Security Exchange Name NASDAQ

Globalink Investment (NASDAQ:GLLIW)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024 Globalink Investment 차트를 더 보려면 여기를 클릭.
Globalink Investment (NASDAQ:GLLIW)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024 Globalink Investment 차트를 더 보려면 여기를 클릭.